Company presentations
HemostOD SA
HemostOD is an early pre-clinical stage Swiss company producing "ex vivo", adult stem cell-derived engineered platelets, for infusion in patients suffering low platelet counts, as in thrombocytopenia and when a patient's own immune system attacks platelet transfusions from human donors.The platelets are manufactured from megakaryocyte cells and mimic the structure and biological properties of fresh human platelets, but with greatly reduced immunogenicity and purer quality.
Date, time and room information
May 6, 16:00 - 16:15, room Singapore
Category
Emerging biotech company
Title of the presentation
We Manufacture Ex-Vivo Platelets - An Alternative to Blood Donation
Speaker information
| Name | Position | Institution |
|---|---|---|
| Faouzi Khechana | CEO | HemostOD SA |
